Purinergic Signaling Research

Specialized in purinergic signaling as it relates to kidney diseases, diet-induced obesity, and metabolic syndrome. One of the few global leaders in purinergic signaling as it applies to the kidney and obesity.

International Work Experience

Possesses decades of experience in medical research across Asia, Europe, and North America.

Academic Background

Recognized as an academician and Adjunct Professor in Internal Medicine.

International Patents

Secured several international patents for novel drug targets.

PhD Degree

Holds a Doctor of Philosophy degree.

Medical Degree (MD)

Holds a Doctor of Medicine degree.

Pharmaceutical Industry

Involved in identifying novel drug targets and evaluating them in animal models

Nephrology Industry

Specialized in kidney research as Principal Investigator in Nephrology.

Master of Business Administration (MBA)

Holds an MBA, providing business acumen for entrepreneurial ventures.

MD Degree

Holds a Medical Doctor degree.

Founded company

Founded ePurines, Inc., a biopharma startup in 2020.

Medical Research Industry

Decades of experience in medical research, with a focus on specific disease areas.

MBA Degree

Holds a Doctor of Medicine (MD), Doctor of Philosophy (PhD) and Executive MBA degrees

Drug Discovery

Identified novel drug targets for water balance disorders, obesity, and insulin resistance.

Doctor of Philosophy (PhD)

Holds a Doctor of Philosophy degree, signifying expertise in research.

Innovation

Recognized as an innovator in medical research and drug development. Inducted as Senior Member of the National Academy of Inventors.

Principal Investigator

Served as a Principal Investigator at a major healthcare system, and in Veterans Affairs Medical Center leading research initiatives.

Drug Target Discovery

Successfully identified novel drug targets for significant medical conditions.

Company Founder

Founded ePurines, Inc., a preclinical drug development startup.

Patented Research

Secured several international patents for novel drug targets.

Leadership

Serves as President, CEO, and CSO, demonstrating strong leadership in both academic and entrepreneurial settings.

Teaching (Higher Education)

Serves as an Adjunct Professor of Internal Medicine.

Endocrinology Industry

Research and development focus on obesity, metabolic syndrome, and insulin resistance.

Healthcare Industry

Extensive background as a physician-scientist and professor in healthcare settings.

Healthcare

Decades of experience in medical research and as a physician.

Entrepreneurship

Founded and leads ePurines, a biopharma startup.

Fundraising (Pre-Seed)

Successfully raised pre-seed funding for a biopharma startup.

CEO Leadership

Serves as President and CEO of a preclinical drug development startup, overseeing all operations.

Biotechnology Industry

Active in the biopharma sector, leading a drug development startup.

Medical Research

Decades of experience as a prominent medical researcher, with a focus on purinergic signaling.

CSO Leadership

Serves as Chief Scientific Officer, guiding scientific strategy and research at ePurines, Inc.

Biotechnology

Extensive experience in the biotechnology sector through ePurines and medical research.

Market Access Strategy

Developed strategies for delivering affordable treatments to global markets, including low- and middle-income countries.

Startup Management

Managing all aspects of an early-stage preclinical drug development startup.

Published Research

As a prominent medical researcher and Principal Investigator, Dr. Kishore has published extensive research.

Drug Target Identification

Identified novel drug targets for various disorders including water balance, obesity, and insulin resistance.

Nephrology

Specialized in Nephrology as a Principal Investigator at VA Salt Lake City Healthcare System.

Purinergic Signaling

Research expertise focused on purinergic signaling related to various diseases.

Pharmaceuticals

Worked in preclinical drug development and therapeutics.

Academia

Holds an Adjunct Professor position and has a long history in medical research within academic institutions.

Drug Development

Led preclinical drug development for novel anti-obesity and metabolic disease therapeutics.

Internal Medicine

Adjunct Professor in Internal Medicine at the University of Utah Health.

Target Identification

Expert in identifying novel drug targets for metabolic and renal diseases.

Therapeutics

Expertise in developing therapeutics, particularly for metabolic and kidney diseases.

Obesity Treatment

Developed anti-obesity therapeutics targeting purinergic signaling pathways.

Preclinical Development

Managing and executing preclinical drug development programs.

Strategic Planning

Developed the strategic direction for ePurines, focusing on accessible metabolic medicine.

Insulin Resistance

Identified drug targets for insulin resistance.

Diet-induced Obesity

Researched diet-induced obesity and metabolic syndrome.

Metabolic Syndrome

Researched metabolic syndrome in relation to purinergic signaling.

Platform Development

Building a platform for accessible metabolic medicine.

Kidney Diseases

Researched purinergic signaling as it relates to kidney diseases.

Raised Funding

Successfully raised between $250k-$500k in pre-seed funding for ePurines.

Water Balance Disorders

Identified drug targets for water balance disorders.

Project Management

Managed multiple research projects as a Principal Investigator.

Intellectual Property Management

Involved in securing several international patents based on research findings.

Energy Metabolism

Focused on improving energy metabolism through novel therapeutic approaches.

Cardiometabolic Health

Developing therapeutics to improve cardiometabolic health.

Global Experience

Gained decades of medical research experience across Asia, Europe, and North America.

Fundraising

Successfully secured pre-seed funding for ePurines.